Medisafe 1 Technologies Clarifies the PR Issued on September 1 for the Stock Dividend, as a Forward Split of 5-1 in the Form of a Stock Dividend September 3, 2010 By Bio-Medicine.Org < ‘/>”/> SOURCE
Catching up with Dr. Tom Oxley as Synchron builds toward a pivotal trial for FDA approval of its Stentrode BCI
Sept. 25-26: Live interviews and audience Q&As with minimally invasive engineers from J&J, Abbott and more
As cardiovascular deaths soar for women, Medtronic’s Nina Goodheart and the medtech industry are responding